{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:26:25Z","timestamp":1791584785436,"version":"4.3.4"},"reference-count":56,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Plasma von Willebrand factor (VWF) and platelet reactivity are risk factors for venous thromboembolism (VTE), and VWF can promote hemostasis by interaction with platelets. In this study, we explored the combined effects of plasma VWF and platelet measures on the risk of incident VTE. A population-based nested case-control study with 403 cases and 816 controls was derived from the Troms\u00f8 Study. VWF, platelet count and mean platelet volume (MPV) were measured in blood samples drawn at baseline. Odds ratios (ORs) with 95% confidence intervals (CIs) for VTE were estimated across VWF tertiles, within predefined MPV (&amp;lt;8.5, 8.5-9.5, and \u22659.5 fL) and platelet count (&amp;lt;230, 230-299, and \u2265300 \u00d7109\/L) strata. Here, participants with VWF levels in the highest tertile and with MPV \u22659.5 fL had an OR of 1.98 (95% CI, 1.17-3.36) for VTE compared with those in the lowest VWF tertile and with MPV &amp;lt;8.5 fL in the age- and sex-adjusted model. In the joint exposure group, 48% (95% CI, 15-96) of VTEs were attributable to the biological interaction between VWF and MPV. Similarly, individuals with VWF in the highest tertile and platelet count \u2265300 \u00d7 109\/L had an OR of 2.91 (95% CI, 1.49-5.67) compared with those with VWF in the lowest tertile and platelet count &amp;lt;230 \u00d7 109\/L, and 39% (95% CI, \u22122 to 97) of VTEs in the joint exposure group were explained by the interaction. Our results suggest that platelet reactivity and platelet count interact biologically with high plasma VWF, resulting in an increased risk for incident VTE.<\/jats:p>","DOI":"10.1182\/blood.2021011494","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T19:01:59Z","timestamp":1624474919000},"page":"2269-2277","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":25,"title":["Combined effects of plasma von Willebrand factor and platelet measures on the risk of incident venous thromboembolism"],"prefix":"10.1182","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5476-7467","authenticated-orcid":false,"given":"Magnus S.","family":"Edvardsen","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, Thrombosis Research Center, UiT\u2013The Arctic University of Norway, Troms\u00f8, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen-Sofie","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Thrombosis Research Center, UiT\u2013The Arctic University of Norway, Troms\u00f8, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-6679","authenticated-orcid":false,"given":"Kristian","family":"Hindberg","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Thrombosis Research Center, UiT\u2013The Arctic University of Norway, Troms\u00f8, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia M.","family":"Morelli","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Thrombosis Research Center, UiT\u2013The Arctic University of Norway, Troms\u00f8, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5005-0784","authenticated-orcid":false,"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Thrombosis Research Center, UiT\u2013The Arctic University of Norway, Troms\u00f8, Norway;"},{"name":"Research Institute of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[{"name":"Research Institute of Internal Medicine and"},{"name":"Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-9696","authenticated-orcid":false,"given":"Sigrid K.","family":"Br\u00e6kkan","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Thrombosis Research Center, UiT\u2013The Arctic University of Norway, Troms\u00f8, Norway;"},{"name":"Division of Internal Medicine, University Hospital of North Norway, Troms\u00f8, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7169-9408","authenticated-orcid":false,"given":"Line H.","family":"Evensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Thrombosis Research Center, UiT\u2013The Arctic University of Norway, Troms\u00f8, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Bjarne","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Thrombosis Research Center, UiT\u2013The Arctic University of Norway, Troms\u00f8, Norway;"},{"name":"Division of Internal Medicine, University Hospital of North Norway, Troms\u00f8, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"9828","key":"2021120216283413200_B1","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(11)61904-1","article-title":"Pulmonary embolism and deep vein thrombosis","volume":"379","author":"Goldhaber","year":"2012","journal-title":"Lancet."},{"issue":"4","key":"2021120216283413200_B2","first-page":"756","article-title":"Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality","volume":"98","author":"Cohen","year":"2007","journal-title":"Thromb Haemost."},{"issue":"11","key":"2021120216283413200_B3","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis: a major contributor to global disease burden","volume":"34","author":"Raskob","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"9","key":"2021120216283413200_B4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.amjmed.2014.03.041","article-title":"Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009)","volume":"127","author":"Huang","year":"2014","journal-title":"Am J Med."},{"key":"2021120216283413200_B5","doi-asserted-by":"crossref","first-page":"I4","DOI":"10.1161\/01.CIR.0000078468.11849.66","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation."},{"issue":"1","key":"2021120216283413200_B6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amjmed.2004.01.018","article-title":"Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology","volume":"117","author":"Cushman","year":"2004","journal-title":"Am J Med."},{"issue":"13","key":"2021120216283413200_B7","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood."},{"issue":"3","key":"2021120216283413200_B8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI112064","article-title":"Biosynthesis of von Willebrand protein by human megakaryocytes","volume":"76","author":"Sporn","year":"1985","journal-title":"J Clin Invest."},{"issue":"1","key":"2021120216283413200_B9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.95.1.355","article-title":"Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells","volume":"95","author":"Wagner","year":"1982","journal-title":"J Cell Biol."},{"issue":"1","key":"2021120216283413200_B10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem."},{"issue":"8","key":"2021120216283413200_B11","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9343(02)01345-1","article-title":"Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)","volume":"113","author":"Tsai","year":"2002","journal-title":"Am J Med."},{"issue":"8943","key":"2021120216283413200_B12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet."},{"issue":"1","key":"2021120216283413200_B13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/bloodadvances.2020003135","article-title":"Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism","volume":"5","author":"Edvardsen","year":"2021","journal-title":"Blood Adv."},{"issue":"5","key":"2021120216283413200_B14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCULATIONAHA.118.034532","article-title":"Genome-wide association transethnic meta-analyses identifies novel associations regulating coagulation factor VIII and von Willebrand factor plasma levels","volume":"139","author":"Sabater-Lleal","year":"2019","journal-title":"Circulation."},{"issue":"2","key":"2021120216283413200_B15","first-page":"169","article-title":"High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites","volume":"24","author":"Payne","year":"2014","journal-title":"Ethn Dis."},{"issue":"6","key":"2021120216283413200_B16","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1182\/blood-2006-06-028241","article-title":"von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins","volume":"109","author":"Chauhan","year":"2007","journal-title":"Blood."},{"issue":"4","key":"2021120216283413200_B17","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1182\/blood-2010-05-287623","article-title":"von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models","volume":"117","author":"Brill","year":"2011","journal-title":"Blood."},{"issue":"11","key":"2021120216283413200_B18","first-page":"785","article-title":"Thrombosis and platelets: an update","volume":"38","author":"Koupenova","year":"2017","journal-title":"Eur Heart J."},{"issue":"2","key":"2021120216283413200_B19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ Res."},{"issue":"3","key":"2021120216283413200_B20","doi-asserted-by":"crossref","first-page":"e92011","DOI":"10.1371\/journal.pone.0092011","article-title":"Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Troms\u00f8 Study","volume":"9","author":"Jensvoll","year":"2014","journal-title":"PLoS One."},{"issue":"2","key":"2021120216283413200_B21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/09537104.2014.894969","article-title":"Hypercoagulation in colorectal cancer: what can platelet indices tell us?","volume":"26","author":"Seretis","year":"2015","journal-title":"Platelets."},{"issue":"5","key":"2021120216283413200_B22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0049-3848(83)90255-4","article-title":"The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration","volume":"32","author":"Martin","year":"1983","journal-title":"Thromb Res."},{"issue":"6","key":"2021120216283413200_B23","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/jth.14788","article-title":"Large and small platelets-(when) do they differ?","volume":"18","author":"Handtke","year":"2020","journal-title":"J Thromb Haemost."},{"issue":"1","key":"2021120216283413200_B24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1538-7836.2009.03498.x","article-title":"Mean platelet volume is a risk factor for venous thromboembolism: the Troms\u00f8 Study, Troms\u00f8, Norway","volume":"8","author":"Braekkan","year":"2010","journal-title":"J Thromb Haemost."},{"key":"2021120216283413200_B25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.thromres.2017.01.010","article-title":"Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study","volume":"151","author":"Puurunen","year":"2017","journal-title":"Thromb Res."},{"issue":"4","key":"2021120216283413200_B26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ije\/dyr049","article-title":"Cohort profile: the Tromso Study","volume":"41","author":"Jacobsen","year":"2012","journal-title":"Int J Epidemiol."},{"key":"2021120216283413200_B27","doi-asserted-by":"crossref","first-page":"i969","DOI":"10.1136\/bmj.i969","article-title":"Analysis of matched case-control studies","volume":"352","author":"Pearce","year":"2016","journal-title":"BMJ."},{"issue":"7","key":"2021120216283413200_B28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10654-005-7835-x","article-title":"Calculating measures of biological interaction","volume":"20","author":"Andersson","year":"2005","journal-title":"Eur J Epidemiol."},{"issue":"4","key":"2021120216283413200_B29","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0002-9343(78)90571-5","article-title":"Heterogeneity of platelet function. Correlation with platelet volume","volume":"64","author":"Karpatkin","year":"1978","journal-title":"Am J Med."},{"issue":"6","key":"2021120216283413200_B30","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1172\/JCI106064","article-title":"Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets","volume":"48","author":"Karpatkin","year":"1969","journal-title":"J Clin Invest."},{"issue":"2","key":"2021120216283413200_B31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood.V62.2.487.487","article-title":"Platelet size does not correlate with platelet age","volume":"62","author":"Thompson","year":"1983","journal-title":"Blood."},{"issue":"3","key":"2021120216283413200_B32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41569-018-0110-0","article-title":"Platelet biology and functions: new concepts and clinical perspectives","volume":"16","author":"van der Meijden","year":"2019","journal-title":"Nat Rev Cardiol."},{"issue":"(1","key":"2021120216283413200_B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/9213074","article-title":"Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions","author":"Korniluk","year":"2019","journal-title":"Mediators Inflamm."},{"issue":"3","key":"2021120216283413200_B34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/blood.V56.3.329.329","article-title":"Autoimmune thrombocytopenic purpura","volume":"56","author":"Karpatkin","year":"1980","journal-title":"Blood."},{"issue":"9678","key":"2021120216283413200_B35","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Antithrombotic Trialists\u2019 (ATT) Collaboration","year":"2009","journal-title":"Lancet."},{"issue":"8780","key":"2021120216283413200_B36","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/0140-6736(91)92719-I","article-title":"Influence of platelet size on outcome after myocardial infarction","volume":"338","author":"Martin","year":"1991","journal-title":"Lancet."},{"issue":"9","key":"2021120216283413200_B37","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2014-05-378638","article-title":"von Willebrand factor, Jedi knight of the bloodstream","volume":"124","author":"Springer","year":"2014","journal-title":"Blood."},{"issue":"2","key":"2021120216283413200_B38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00018-014-1743-8","article-title":"Of von Willebrand factor and platelets","volume":"72","author":"Bryckaert","year":"2015","journal-title":"Cell Mol Life Sci."},{"issue":"5","key":"2021120216283413200_B39","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/oxfordjournals.aje.a112252","article-title":"The estimation of synergy or antagonism","volume":"103","author":"Rothman","year":"1976","journal-title":"Am J Epidemiol."},{"issue":"6","key":"2021120216283413200_B40","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1160\/TH14-06-0563","article-title":"Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation","volume":"113","author":"Riva","year":"2015","journal-title":"Thromb Haemost."},{"issue":"10063","key":"2021120216283413200_B41","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/S0140-6736(16)30514-1","article-title":"Deep vein thrombosis and pulmonary embolism","volume":"388","author":"Di Nisio","year":"2016","journal-title":"Lancet."},{"issue":"12","key":"2021120216283413200_B42","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/ATVBAHA.120.314690","article-title":"von Willebrand factor is a critical mediator of deep vein thrombosis in a mouse model of diet-induced obesity","volume":"40","author":"Michels","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"3","key":"2021120216283413200_B43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12288-019-01092-y","article-title":"Elevated von Willebrand factor antigen levels are an independent risk factor for venous thromboembolism: first report from North India","volume":"35","author":"Rajpal","year":"2019","journal-title":"Indian J Hematol Blood Transfus."},{"issue":"3","key":"2021120216283413200_B44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-0037-1605564","article-title":"von Willebrand factor and venous thromboembolism: pathogenic link and therapeutic implications","volume":"44","author":"Calabr\u00f2","year":"2018","journal-title":"Semin Thromb Hemost."},{"key":"2021120216283413200_B45","doi-asserted-by":"crossref","first-page":"5620314","DOI":"10.1155\/2017\/5620314","article-title":"The role of von Willebrand factor in vascular inflammation: from pathogenesis to targeted therapy","volume":"2017","author":"Gragnano","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"3","key":"2021120216283413200_B46","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1538-7836.2008.03267.x","article-title":"Platelet count and the risk for thrombosis and death in the elderly","volume":"7","author":"van der Bom","year":"2009","journal-title":"J Thromb Haemost."},{"issue":"10","key":"2021120216283413200_B47","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/archinte.162.10.1182","article-title":"Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology","volume":"162","author":"Tsai","year":"2002","journal-title":"Arch Intern Med."},{"key":"2021120216283413200_B48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.thromres.2016.08.012","article-title":"Platelet count is associated with cardiovascular disease, cancer and mortality: A population-based cohort study","volume":"148","author":"Vinholt","year":"2016","journal-title":"Thromb Res."},{"issue":"3","key":"2021120216283413200_B49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tmrv.2004.03.003","article-title":"Relationship between platelet count and bleeding risk in thrombocytopenic patients","volume":"18","author":"Slichter","year":"2004","journal-title":"Transfus Med Rev."},{"issue":"5","key":"2021120216283413200_B50","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1160\/TH13-04-0352","article-title":"Platelet count and outcome in patients with acute venous thromboembolism","volume":"110","author":"Di Micco","year":"2013","journal-title":"Thromb Haemost."},{"issue":"13","key":"2021120216283413200_B51","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1182\/blood-2015-06-654764","article-title":"U-shaped mortality curve associated with platelet count among older people: a community-based cohort study","volume":"126","author":"Tsai","year":"2015","journal-title":"Blood."},{"issue":"4","key":"2021120216283413200_B52","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/09537104.2020.1769052","article-title":"Platelet count and risk of major bleeding in venous thromboembolism","volume":"32","author":"Johnsen","year":"2021","journal-title":"Platelets"},{"issue":"2","key":"2021120216283413200_B53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia."},{"issue":"5","key":"2021120216283413200_B54","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1309\/AJCPRU5QLKLQ0OMS","article-title":"Measurement of hemostatic factors in EDTA plasma","volume":"130","author":"Green","year":"2008","journal-title":"Am J Clin Pathol."},{"key":"2021120216283413200_B55","article-title":"The effects of EDTA as an anticoagulant and delayed processing on the measurement of plasma VWF antigen [abstract]","author":"Sims"},{"key":"2021120216283413200_B56","first-page":"71","volume-title":"Modern Epidemiology.","author":"Greenland","year":"2008","edition":"3rd ed"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/138\/22\/2269\/1848157\/bloodbld2021011494.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/138\/22\/2269\/1848157\/bloodbld2021011494.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T16:49:59Z","timestamp":1638463799000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/138\/22\/2269\/476238\/Combined-effects-of-plasma-von-Willebrand-factor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":56,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2021,12,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021011494","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]}}}